187 related articles for article (PubMed ID: 21215809)
1. Influence of GST gene polymorphisms on the clearance of intravenous busulfan in adult patients undergoing hematopoietic cell transplantation.
Kim SD; Lee JH; Hur EH; Lee JH; Kim DY; Lim SN; Choi Y; Lim HS; Bae KS; Noh GJ; Yun SC; Han SB; Lee KH
Biol Blood Marrow Transplant; 2011 Aug; 17(8):1222-30. PubMed ID: 21215809
[TBL] [Abstract][Full Text] [Related]
2. Influence of glutathione S-transferase A1, P1, M1, T1 polymorphisms on oral busulfan pharmacokinetics in children with congenital hemoglobinopathies undergoing hematopoietic stem cell transplantation.
Elhasid R; Krivoy N; Rowe JM; Sprecher E; Adler L; Elkin H; Efrati E
Pediatr Blood Cancer; 2010 Dec; 55(6):1172-9. PubMed ID: 20672371
[TBL] [Abstract][Full Text] [Related]
3. Glutathione S-transferase polymorphisms are not associated with population pharmacokinetic parameters of busulfan in pediatric patients.
Zwaveling J; Press RR; Bredius RG; van Derstraaten TR; den Hartigh J; Bartelink IH; Boelens JJ; Guchelaar HJ
Ther Drug Monit; 2008 Aug; 30(4):504-10. PubMed ID: 18641537
[TBL] [Abstract][Full Text] [Related]
4. Influence of GST gene polymorphisms on busulfan pharmacokinetics in children.
Ansari M; Lauzon-Joset JF; Vachon MF; Duval M; Théoret Y; Champagne MA; Krajinovic M
Bone Marrow Transplant; 2010 Feb; 45(2):261-7. PubMed ID: 19584821
[TBL] [Abstract][Full Text] [Related]
5. Effect of genetic polymorphisms in genes encoding GST isoenzymes on BU pharmacokinetics in adult patients undergoing hematopoietic SCT.
ten Brink MH; Wessels JA; den Hartigh J; van der Straaten T; von dem Borne PA; Guchelaar HJ; Zwaveling J
Bone Marrow Transplant; 2012 Feb; 47(2):190-5. PubMed ID: 21441958
[TBL] [Abstract][Full Text] [Related]
6. Influence of glutathione S-transferase A1 polymorphism on the pharmacokinetics of busulfan.
Kusama M; Kubota T; Matsukura Y; Matsuno K; Ogawa S; Kanda Y; Iga T
Clin Chim Acta; 2006 Jun; 368(1-2):93-8. PubMed ID: 16448639
[TBL] [Abstract][Full Text] [Related]
7. Population pharmacokinetic analysis of intravenous busulfan: GSTA1 genotype is not a predictive factor of initial dose in Chinese adult patients undergoing hematopoietic stem cell transplantation.
Sun Y; Huang J; Hao C; Li Z; Liang W; Zhang W; Chen B; Yang W; Hu J
Cancer Chemother Pharmacol; 2020 Feb; 85(2):293-308. PubMed ID: 31834435
[TBL] [Abstract][Full Text] [Related]
8. Influence of GST polymorphisms on busulfan pharmacokinetics in Japanese children.
Nishikawa T; Yamaguchi H; Ikawa K; Nakayama K; Higashi E; Miyahara E; Abematsu T; Nakagawa S; Kodama Y; Tanabe T; Shigemi A; Shinkoda Y; Okamoto Y; Takeda Y; Kawano Y
Pediatr Int; 2019 Jun; 61(6):558-565. PubMed ID: 30963629
[TBL] [Abstract][Full Text] [Related]
9. Impact of Glutathione S-Transferase Polymorphisms on Busulfan Pharmacokinetics and Outcomes of Hematopoietic Stem Cell Transplantation.
Al-Riyami I; Al-Khabori M; Al Balushi K; Al-Zadjali S; Al-Rawahi M; Dennison D; Al-Hunaini M; Al-Rawas A; Al-Moundhri M
Ther Drug Monit; 2022 Aug; 44(4):527-534. PubMed ID: 34990437
[TBL] [Abstract][Full Text] [Related]
10. Influence of fludarabine on the pharmacokinetics of oral busulfan during pretransplant conditioning for hematopoietic stem cell transplantation.
de Castro FA; Lanchote VL; Voltarelli JC; Colturato VA; Simões BP
J Clin Pharmacol; 2013 Nov; 53(11):1205-11. PubMed ID: 23955479
[TBL] [Abstract][Full Text] [Related]
11. Analysis of glutathione S-transferase and cytochrome P450 gene polymorphism in recipients of dose-adjusted busulfan-cyclophosphamide conditioning.
Terakura S; Onizuka M; Fukumoto M; Kuwatsuka Y; Kohno A; Ozawa Y; Miyamura K; Inagaki Y; Sawa M; Atsuta Y; Suzuki R; Naoe T; Morishita Y; Murata M;
Int J Hematol; 2020 Jan; 111(1):84-92. PubMed ID: 31555969
[TBL] [Abstract][Full Text] [Related]
12. Effect of glutathione S-transferase genetic polymorphisms on busulfan pharmacokinetics and veno-occlusive disease in hematopoietic stem cell transplantation: A meta-analysis.
Kim MG; Kwak A; Choi B; Ji E; Oh JM; Kim K
Basic Clin Pharmacol Toxicol; 2019 Jun; 124(6):691-703. PubMed ID: 30511436
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenetics of intravenous and oral busulfan in hematopoietic cell transplant recipients.
Abbasi N; Vadnais B; Knutson JA; Blough DK; Kelly EJ; O'Donnell PV; Deeg HJ; Pawlikowski MA; Ho RJ; McCune JS
J Clin Pharmacol; 2011 Oct; 51(10):1429-38. PubMed ID: 21135089
[TBL] [Abstract][Full Text] [Related]
14. Glutathione S-transferase A1 polymorphisms and acute graft-vs.-host disease in HLA-matched sibling allogeneic hematopoietic stem cell transplantation.
Kim I; Keam B; Lee KH; Kim JH; Oh SY; Ra EK; Yoon SS; Park SS; Kim CS; Park S; Hong YC; Kim BK
Clin Transplant; 2007; 21(2):207-13. PubMed ID: 17425746
[TBL] [Abstract][Full Text] [Related]
15. Glutathione S-transferase gene variations influence BU pharmacokinetics and outcome of hematopoietic SCT in pediatric patients.
Ansari M; Rezgui MA; Théoret Y; Uppugunduri CR; Mezziani S; Vachon MF; Desjean C; Rousseau J; Labuda M; Przybyla C; Duval M; Champagne M; Peters C; Bittencourt H; Krajinovic M;
Bone Marrow Transplant; 2013 Jul; 48(7):939-46. PubMed ID: 23292236
[TBL] [Abstract][Full Text] [Related]
16. Effect of genetic variants GSTA1 and CYP39A1 and age on busulfan clearance in pediatric patients undergoing hematopoietic stem cell transplantation.
ten Brink MH; van Bavel T; Swen JJ; van der Straaten T; Bredius RG; Lankester AC; Zwaveling J; Guchelaar HJ
Pharmacogenomics; 2013 Nov; 14(14):1683-90. PubMed ID: 24192117
[TBL] [Abstract][Full Text] [Related]
17. Precision dosing of intravenous busulfan in pediatric hematopoietic stem cell transplantation: Results from a multicenter population pharmacokinetic study.
Ben Hassine K; Nava T; Théoret Y; Nath CE; Daali Y; Kassir N; Lewis V; Bredius RGM; Shaw PJ; Bittencourt H; Krajinovic M; Uppugunduri CRS; Ansari M
CPT Pharmacometrics Syst Pharmacol; 2021 Sep; 10(9):1043-1056. PubMed ID: 34453497
[TBL] [Abstract][Full Text] [Related]
18. Population pharmacokinetics and pharmacodynamics of busulfan with GSTA1 polymorphisms in patients undergoing allogeneic hematopoietic stem cell transplantation.
Choi B; Kim MG; Han N; Kim T; Ji E; Park S; Kim IW; Oh JM
Pharmacogenomics; 2015; 16(14):1585-94. PubMed ID: 26419450
[TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphisms of glutathione S-transferase A1, the major glutathione S-transferase in human liver: consequences for enzyme expression and busulfan conjugation.
Bredschneider M; Klein K; Mürdter TE; Marx C; Eichelbaum M; Nüssler AK; Neuhaus P; Zanger UM; Schwab M
Clin Pharmacol Ther; 2002 Jun; 71(6):479-87. PubMed ID: 12087351
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic-directed high-dose busulfan combined with cyclophosphamide and etoposide results in predictable drug levels and durable long-term survival in lymphoma patients undergoing autologous stem cell transplantation.
Zhang H; Graiser M; Hutcherson DA; Dada MO; McMillan S; Ali Z; Flowers CR; Waller EK
Biol Blood Marrow Transplant; 2012 Aug; 18(8):1287-94. PubMed ID: 22370160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
